Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids.

Hybrids between immortal cells that express telomerase and normal cells that lack telomerase have a limited lifespan. We demonstrate that telomerase is repressed in such hybrids. Treatment of immortal human cell lines with certain oligonucleotides resulted in telomere elongation. We took advantage of this observation to test the hypothesis that elongation of telomeres would extend the lifespan of cells in culture. An immortal human cell line was treated with an oligonucleotide to lengthen its telomeres and then was fused with mortal cells. The lifespan of these hybrid cells was longer than that of the hybrids in which telomeres had not been elongated. These observations provide the first direct evidence supporting the hypothesis that telomere length determines proliferative capacity of human cells.

[1]  J. Shay,et al.  Telomerase activity in human cancer. , 1996, Current opinion in oncology.

[2]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[3]  D. Broccoli,et al.  Telomerase activity in normal and malignant hematopoietic cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Shay,et al.  Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. , 1995, Nucleic acids research.

[5]  M. Blasco,et al.  Functional characterization and developmental regulation of mouse telomerase RNA , 1995, Science.

[6]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[7]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[8]  J. Shay,et al.  Telomerase activity in gastric cancer. , 1995, Cancer research.

[9]  J. Shay,et al.  Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. , 1995, Cancer research.

[10]  S. Gallinger,et al.  Telomerase activity associated with acquisition of malignancy in human colorectal cancer. , 1995, Cancer research.

[11]  C. Greider,et al.  Developmental and tissue-specific regulation of mouse telomerase and telomere length. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Shay,et al.  Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP) , 1995 .

[13]  Keiko Hiyama,et al.  Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.

[14]  C B Harley,et al.  Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Murnane,et al.  Telomere dynamics in an immortal human cell line. , 1994, The EMBO journal.

[16]  G. Roos,et al.  Telomerase activity in vivo in human malignant hematopoietic cells. , 1994, Oncogene.

[17]  E. Blackburn,et al.  A conserved sequence motif within the exceptionally diverse telomeric sequences of budding yeasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Harley,et al.  Telomerase activity in human ovarian carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  V. Maher,et al.  Failure of infinite life span human cells from different immortality complementation groups to yield finite life span hybrids , 1994, Journal of cellular physiology.

[20]  J. R. Smith,et al.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[21]  E. Parkinson,et al.  Assignment of two human epidermal squamous cell carcinoma cell lines to more than one complementation group for the immortal phenotype , 1994, Molecular carcinogenesis.

[22]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[23]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[24]  J. Shay,et al.  Loss of telomeric DNA during aging may predispose cells to cancer (review). , 1993, International journal of oncology.

[25]  J. Shay,et al.  E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. , 1993, Oncogene.

[26]  C B Harley,et al.  Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. , 1993, American journal of human genetics.

[27]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C B Harley,et al.  Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.

[29]  J. Shay,et al.  Telomere positional effects and the regulation of cellular senescence. , 1992, Trends in genetics : TIG.

[30]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[31]  T. de Lange.  Human telomeres are attached to the nuclear matrix. , 1992, The EMBO journal.

[32]  E. Blackburn,et al.  Developmentally programmed healing of chromosomes by telomerase in tetrahymena , 1991, Cell.

[33]  Daniel P. Romero,et al.  A conserved secondary structure for telomerase RNA , 1991, Cell.

[34]  L. Harrington.  Telomerase primer specificity and chromosome healing , 1991, Nature.

[35]  J. Shay,et al.  A role for both RB and p53 in the regulation of human cellular senescence. , 1991, Experimental cell research.

[36]  E. Hara,et al.  Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. , 1991, Biochemical and biophysical research communications.

[37]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[38]  G. Morin.  Recognition of a chromosome truncation site associated with alpha-thalassaemia by human telomerase. , 1991, Nature.

[39]  H. Cooke,et al.  In vivo loss of telomeric repeats with age in humans. , 1991, Mutation research.

[40]  Barbara L. Billington,et al.  Position effect at S. cerevisiae telomeres: Reversible repression of Pol II transcription , 1990, Cell.

[41]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[42]  C. Greider.  Telomeres, telomerase and senescence , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.

[43]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[44]  V. Zakian,et al.  Telomere telomere recombination provides an express pathway for telomere acquisition , 1990, Nature.

[45]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[46]  R. Moyzis,et al.  Conservation of the human telomere sequence (TTAGGG)n among vertebrates. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  V. Zakian,et al.  Recombination occurs during telomere formation in yeast , 1989, Nature.

[48]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.

[49]  A. Zahler,et al.  Telomere terminal transferase activity in the hypotrichous ciliate Oxytricha nova and a model for replication of the ends of linear DNA molecules. , 1988, Nucleic acids research.

[50]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[51]  J. R. Smith,et al.  Evidence for the recessive nature of cellular immortality. , 1983, Science.

[52]  O. Pereira-smith,et al.  Phenotype of low proliferative potential is dominant in hybrids of normal human fibroblasts , 1982, Somatic cell genetics.

[53]  D. DeSimone,et al.  Replicative potentials of various fusion products between WI-38 and SV40 transformed WI-38 cells and their components , 1980, Somatic cell genetics.

[54]  C. Bunn,et al.  Limited lifespan in somatic cell hybrids and cybrids. , 1980, Experimental cell research.